BETHESDA, MD 07 November 2012—Boehringer Ingelheim Pharmaceuticals Inc. on November 7 announced the recall of one lot of dabigatran etexilate mesylate because of a problem with the drug's packaging.
The recall affects lot 201900, which contains 75-mg capsules of the anticoagulant and bears an expiration date of January 2015. According to Boehringer Ingelheim, a packaging defect may allow moisture to enter the bottles and reduce the effectiveness of the drug.
The company instructed patients to continue using the recalled lot until they can obtain a free replacement from their pharmacy. Boehringer Ingelheim has asked pharmacists to contact patients who received the recalled lot and ask them to return it to the pharmacy.
A "recall packet" for pharmacists and distributors is available from Genco Pharmaceutical Services of Milwaukee. The company can be contacted by phone at 877-319-8963 for information about the recall process.
For questions, comments, or
more information on this
article, please contact the
ASHP News Center at email@example.com.
Stay connected with ASHP through our social media tools.
What We Do
For the Press
Jobs at ASHP
AHFS Drug Information
Customer Service: 1-866-279-0681
8:00am - 6:00pm ET, Mon-Fri
American Society of Health-System Pharmacists. All rights reserved. 7272 Wisconsin Avenue, Bethesda, MD 20814